Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2020-02-21 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Roadshow Frankfurt
Investor Presentation Classification · 99% confidence The document is a presentation titled 'Roadshow – Frankfurt' dated February 21, 2020. It contains detailed financial performance reviews for FY/19, segment-specific operational updates (Fresenius Kabi, Helios, Vamed), and financial guidance/outlook for FY/20. The structure, use of slides/bullet points, and focus on summarizing past performance and future expectations strongly indicate an Investor Presentation (IP) or a document closely related to an earnings release/investor day. Since it is a detailed presentation format covering multiple segments and providing medium-term targets, 'Investor Presentation' (IP) is the most appropriate classification over a simple 'Earnings Release' (ER) which usually contains only the headline numbers.
2020-02-21 English
Conference Call Full Year Results 2019, Fresenius
Investor Presentation Classification · 100% confidence The document is titled "Conference Call – FY/19 Results" and contains detailed operational and financial highlights for the fiscal year 2019, along with outlooks for FY/20. It includes forward-looking statements, segment performance reviews (Fresenius Kabi, Helios, Vamed), profit and loss statements, and cash flow analysis. This structure is characteristic of materials presented during or immediately following an earnings announcement, often accompanied by a conference call. Since the text is a presentation summarizing results and includes a 'Safe Harbor Statement' typical of such events, it strongly aligns with the content of an Earnings Release (ER) or a presentation accompanying it, which often overlaps with the content discussed in a Call Transcript (CT). Given the format is a presentation summarizing results rather than a full transcript, and it focuses on key financial highlights and outlooks, it is best classified as an Earnings Release (ER) or Investor Presentation (IP). However, the title explicitly mentions 'Conference Call', and the content is structured like presentation slides used during such a call. In many databases, detailed presentations accompanying earnings calls are classified as Investor Presentations (IP). Since it is a detailed presentation covering FY/19 results and FY/20 outlook, IP is a strong fit. If the primary purpose was the initial announcement of results (key highlights only), ER would fit. Given the depth (P&L tables, segment breakdowns, medium-term targets), Investor Presentation (IP) is the most precise fit among the options for detailed presentation materials.
2020-02-20 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing 'Notification of Major Holdings' under German securities law (WpHG). It reports changes in the percentage of voting rights held by Allianz Global Investors GmbH, crossing a threshold (from 4.995% to 5.09%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels. Although the header mentions 'Voting Rights Announcements', the content is a formal notification of a change in major shareholding percentage, which aligns best with the 'Major Shareholding Notification' code (MRQ). The document is not a general regulatory filing (RNS) because it fits a more specific category, nor is it a proxy solicitation (PSI) or director's dealing (DIRS).
2020-02-12 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a specific entity (Allianz Global Investors GmbH) in Fresenius SE & Co. KGaA, referencing German securities law (WpHG). This directly corresponds to the definition of reporting changes in significant share ownership thresholds. Reviewing the definitions: - 10-K/IR: Not a full annual or interim report. - ER: Not an earnings release. - DVA: This is about voting rights, but DVA is specifically for *results* of a vote, not changes in holding percentages. - MRQ (Major Shareholding Notification): This category perfectly matches the content, which details the crossing or reaching of a threshold for voting rights/share ownership. Therefore, the classification is Major Shareholding Notification (MRQ).
2020-02-10 English
Roadshow Paris
Investor Presentation Classification · 100% confidence The document is titled "Roadshow Paris" and dated March 04, 2020. It contains extensive slides detailing the company's global sales base, track record, segment performance (Fresenius Medical Care, Kabi, Helios, Vamed), growth drivers, strategy, ESG priorities, capital deployment, dividend policy, and a review of FY/19 results with outlooks for 2020-2023. This structure is characteristic of an Investor Presentation (IP) used for roadshows or investor days, rather than a formal regulatory filing like a 10-K or a brief Earnings Release (ER). It is a detailed presentation for investors.
2020-02-04 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Total Voting Rights Announcement' and explicitly states the 'Publication of total number of voting rights' as of 31.01.2020. It details a 'Type of capital measure' related to a 'Conditional capital increase' and provides the 'New total number of voting rights'. This content directly relates to changes in the company's capital structure or voting rights, which aligns best with the 'Capital/Financing Update' (CAP) category, as it announces a change affecting the total number of shares/votes, or potentially 'Share Issue/Capital Change' (SHA). Given the focus on the total voting rights resulting from a capital measure, SHA is a strong fit, but CAP covers financing activities broadly. However, the most specific category for changes in the number of shares/capital structure is SHA. Since this is a formal announcement regarding the total voting rights following a capital measure, SHA is the most precise classification.
2020-01-31 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.